-
The Incredible Egg
in PRESS RELEASE 2003 onWorld renowned infertility clinicians and scientists gather to debate the newest research into the complexities of human eggs (oocytes) which form the basis of the human embryo…
-
Counting the Costs of Nightly Visits to the Bathroom – Businesses lose € 14 million Euros each year in reduced productivity
in PRESS RELEASE 2003 onNew research reveals that a largely ignored health problem, affecting nearly 40 million people in Europe…
-
Her Majesty the Queen of Sweden Addresses Salk Institute Meeting on Childhood Diseases in Stockholm
in PRESS RELEASE 2003 onHer Majesty the Queen of Sweden will officially open the Salk Institute’s annual International Council meeting at the Grand Hotel in Stockholm…
-
Ferring featured in the American Medical Review ™ television series
in PRESS RELEASE 2003 onFerring will be featured on the television programme American Medical Review this spring Season on American Public Television…
-
New website about primary nocturnal enuresis opened in Scandinavia
in PRESS RELEASE 2003 onFerring Pharmaceuticals is proud to announce the launch of the website www.dryallnight.com…
-
First international consultation on nocturia sheds light on neglected disease area
in PRESS RELEASE 2003 onAn international congress has been established by a panel of world leading experts to educate urologists and GPs about the neglected disease area called Nocturia. Nocturia means waking to urinate more than once a night regularly…
-
Ferring International Center opens for business
in TIMELINES onOn January 1st the new Ferring International Center building in Ørestad, Copenhagen opened for business. With its 20 floors, designed…
0 -
5-ASAs/mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)
in PRESS RELEASE 2002 onMore evidence that taking your medication does a body good: Results of a recent study from the UK suggests that Inflammatory Bowel Disease patients (IBD) who take their 5-ASA/mesalazine medicine…
-
Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaboration Agreement
in PRESS RELEASE 2002 onCOPENHAGEN, DK. and BOSTON, MASS. — Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center (BIDMC) today announced they have signed a collaborative agreement to…
-
Ferring and Johnson & Johnson Join in a Research Collaboration
in PRESS RELEASE 2002 onFerring announced today that it will collaborate with Ortho-McNeil Pharmaceuticals Inc. (Ortho-McNeil) and Ortho-McNeil’s research affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)…
Author archive for pulse
Articles by: pulse
